Announce your event here
Digital Pathology Congress: USA
2017-07-10 to 2017-07-11
Palmer House Hilton Hotel, Chicago, IL, USA
As experts position themselves for FDA-approval of primary diagnosis,
the congress will examine the applications and benefits of adopting
digital pathology as well as the business case to be made for it. With
over 200 industry and academic experts expected over the two days, the
congress will provide the opportunity to take home cutting edge
strategies, analysis techniques, case study examples and methods to
allow you to fully understand both the technology and accompanying
informatics and image analysis tools and utilize digital pathology to
its greatest potential. link

6th International Conference on Biotechnology and Bioengineering
2017-09-26 to 2017-09-28
Offenburg, Germany
The 6th International Conference on Biotechnology and Bioengineering (6-ICBB 2017) will be held in Offenburg, Germany during 26–28 September, 2017.
The conference has been designed to provide an innovative and comprehensive overview of biotechnology and bioengineering, and a focus will be given to major research advances, including: New Approaches and Concepts in Biotechnology; Cell and Immunology; Genomics and Molecular Biology; Enzyme and Protein Engineering; Biomedicine, Pharmaceutical Biotechnology and Toxicology; Bioinformatics and Systems Biology; Biomedical Engineering; Biomedical Techniques and Technologies, and other related aspects. More information about the conference can be found at link

7th. InterAmerican Oncology Conference
2017-10-05 to 2017-10-06
Buenos Aires, Argentina

The 7th InterAmerican Oncology Conference "Current Status and Future of Anti-Cancer Targeted Therapies" will be held in Buenos Aires, Argentina in October 5th and 6th, 2017.

An outstanding faculty of speakers from the United States and Europe has committed in this meeting.

The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development. link

4th Annual Drug Discovery USA Congress
2017-10-09 to 2017-10-10
San Diego, USA
Oxford Global’s 4th Annual Drug Discovery USA Congress will take place on 9 – 10 October 2017 in San Diego, USA, bringing together over 250 key opinion leaders in drug discovery. This exciting conference showcases the latest technologies and approaches being utilised across Immuno-therapy, Autoimmune diseases, Neuroscience and Oncology. Further sessions consider the key updates in medicinal and computational chemistry. The two-day congress offers an interactive platform for high level discussions, ensuring valuable networking and interactive sessions.
View Agenda:
4 Interactive Streams:
• Drug Discovery Innovation and Strategies, Enabling Technologies for Immuno-therapy, Autoimmune Diseases, Neuroscience & Oncology
• Successful Phenotypic Drug Discovery: High Content Screening
• Discovery Chemistry: Medicinal and Computational Chemistry
• Discovery Chemistry: Medicinal Chemistry and Novel Approaches to Drug Design link

2nd Annual Biomarkers & Precision Medicine USA Congress
2017-10-09 to 2017-10-10
San Diego, USA

Oxford Global Conferences are proud to present the 2nd Annual Biomarkers & Precision Medicine USA Congress co-located with our 4th Annual Drug Discovery USA Congress, taking place on the 09-10 October 2017 in San Diego, USA.

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.

Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers.

5 Interactive Streams:

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our 4th Annual Drug Discovery USA Congress.

Free Pre-Congress Webinars

Translational Biomarkers and Companion Diagnostics Development Consortium
22nd June 2017, 9 am. PST, 12 noon EST, 5 pm. BST

Click here to register today, for free.

Scientific and Regulatory Considerations for the Analytical Validation of Assays for the Qualification of Biomarkers

8th August 2017, 9 am. PST, 12 noon EST, 5 pm. BST
Click here to register today, for free.

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, click here: link

9th World Congress of Melanoma and the 14th International Congress of the Society for Melanoma Research
2017-10-18 to 2017-10-21
Brisbane, Australia

The 9th World Congress of Melanoma and the 14th International Congress of the Society for Melanoma Research will be held from 18th to 21st October 2017 in Brisbane, Australia. The joint meeting will bring together the world’s leading melanoma researchers and clinicians to showcase the latest developments in melanoma diagnosis, treatment and research.

This global summit will accelerate scientific and clinical investigations into melanoma, providing an opportunity for delegates from multi-disciplinary fields to meet in a warm climate to exchange knowledge and expertise.

We plan to inspire new partnerships and innovations, and will offer a range of significant benefits to international delegates from across the world, including opportunities to explore new professional horizons that pivot from a uniquely global focus on melanoma and skin cancer control. link

3rd Annual NGS & Clinical Diagnostics USA Congress
2017-10-23 to 2017-10-24
Boston, USA
Oxford Global are pleased to announce the 3rd Annual NGS & Clinical Diagnostics USA Congress, taking place on 23-24 October 2017 in Boston USA. Join over 180 delegates representing internationally renowned research & academic institutions, clinical and research institutions, as well as leading pharmaceutical and biotech companies. Hear over 60 presentations and case studies focused on NGS data analysis, utilising NGS in different therapeutic areas as well as NGS in precision medicine and diagnostics development. link

3rd World Congress on Controversies in Breast Cancer (CoBrCa)
2017-10-26 to 2017-10-28
Tokyo, Japan
The 3rd World Congress on Controversies in Breast Cancer (CoBrCa) will take place October 26-28, 2017 in Tokyo, Japan. It will directly address controversial issues in breast cancer faced by clinicians in their daily practice. The congress will focus on key issues in medical oncology, surgery, radiation oncology, reconstruction and pathology. The congress will also provide a forum to effectively debate these unresolved clinical and therapeutic problems. link

2017 NCRI Cancer Conference
2017-11-05 to 2017-11-08
BT Convention Centre, Liverpool, UK

The NCRI Cancer Conference is the largest annual cancer research meeting in the UK, attracting over 1,500 participants from across the spectrum of basic, translational and clinical research. We are committed to share and make available to all attendees the best cancer research from all over the world and encourage cross-pollination. The Conference provides a high profile platform where key stakeholders of cancer research come together to discuss, present and showcase high-quality research. The programme covers six main themes - Diagnosis and therapy, Epidemiology and prevention, Health services research, Information, patients and the public, Survivorship and end of life care and the cancer cell and model systems – which are organised in sessions across 4 days. The Conference programme includes plenty of networking opportunities, allowing participants to make the most of their time in Liverpool.

Key dates:
Abstract submission: 3 April – 4 June
Earlybird registration: 3 April – 30 June
Standard registration: 1 July – 22 October
Late breaking abstract submission: 31 July – 28 August link